Integrated analysis of different microarray studies to identify candidate genes in type 1 diabetes

Area of Science:

• Immunology
• Genomics
• Metabolomics

Background:

• Type 1 diabetes (T1D) is an autoimmune disease primarily affecting children.
• Identifying gene expression alterations in peripheral blood mononuclear cells (PBMCs) is crucial for developing T1D treatments.
• Understanding these changes may help preserve or improve beta-cell function in T1D patients.

Purpose of the Study:

• To identify differentially expressed genes (DEGs) in PBMCs of T1D patients compared to normal controls (NC).
• To analyze the functions and pathways associated with these DEGs.
• To uncover potential novel therapeutic targets for T1D.

Main Methods:

• Searched the Gene Expression Omnibus database for relevant microarray studies.
• Integrated gene expression datasets from multiple studies to identify DEGs.
• Performed gene ontology and pathway analyses, including protein-protein interaction network analysis.

Main Results:

• Analyzed data from 199 T1D samples and 74 NC samples across four microarray studies.
• Identified 695 significantly differentially expressed genes (450 upregulated, 245 downregulated) in T1D PBMCs.
• Enriched pathways included signal transduction and protein binding; arachidonic acid metabolism was the most significant pathway. Key hub proteins identified: ICT1, ZBTB16, and SERTAD1.

Conclusions:

• This integrated analysis highlights significant gene expression differences in T1D PBMCs.
• Identified key biological processes, molecular functions, and metabolic pathways involved in T1D.
• The findings provide a foundation for developing novel therapeutic strategies and identifying new drug targets for Type 1 diabetes.